Age 18 years or older
Symptomatic or asymptomatic coronary artery disease patients
MLA(minimal luminal area)<4mm2
plaque burden>70%
Lipid-rich plaque on NIRS(Intracoronary Near-Infrared Spectroscopy) (defined as maxLCBI4mm>315)
2 target vulnerable lesions
Eligible for percutaneous coronary intervention with Absorb Bioresorbable Vascular Scaffold or Everolimus Eluting Stent
Willing and able to provide informed written consent
Reference vessel diameter 2.75-4.0
Lesion length = 40
